TapImmune Inc. Prevails In Legal Dispute With Michael Gardner

free biotech news Get the latest biotech news where you want it. Sign up for the free GenePool newsletter today!

SEATTLE--(BUSINESS WIRE)--TapImmune Inc. (OTCQB:TPIV), announces successful outcome of proceedings against Michael Gardner after almost 2 years of litigation.

The International Center for Dispute Resolution International Arbitration Tribunal has found that Mr. Gardner made numerous false representations, did not fully provide the services he was hired to perform and did not intend to perform them at the time he was hired.

In addition, the arbitrator found that Mr. Gardner knew that TapImmune would be hindered by his arrangement and compensation with significant stock of the Company and that he had fraudulently induced the company into the agreement through misrepresentation and omission about his reputation and past history and ability to obtain funding for the Company.

Help employers find you! Check out all the jobs and post your resume.

Back to news